From: The BraveNet prospective observational study on integrative medicine treatment approaches for pain
Measure | Baseline | 6-week study visit | 12-week study visit | 24-week study visit | Mean 24-week change from baseline | P valueb |
---|---|---|---|---|---|---|
CES-D (0c–60) | 17.9 (10.49) | 16.1 (10.93) | 15.9 (11.83) | 13.8 (11.02) | −4.0d | <.001 |
PSS-4 (0c–16) | 6.7 (3.14) | 6.2 (3.21) | 5.9 (3.52) | 6.1 (3.64) | −1.1d | <.001 |
SF-12v2 mental (0–100c) | 43.5 (10.44) | 45.4 (10.34) | 45.6 (10.67) | 46.5 (10.97) | 3.1d | <.001 |
SF-12v2 physical (0–100c) | 37.7 (10.24) | 39.4 (10.61) | 40.7 (10.72) | 41.5 (11.56) | 3.7d | <.001 |
Quality of sleep (0–10c) | 4.7 (2.91) | 5.0 (2.95) | 5.1 (2.82) | 5.3 (2.80) | 0.7d | <.001 |
Fatigue scale (0c–10) | 5.8 (2.19) | 5.4 (2.32) | 5.2 (2.36) | 4.9 (2.55) | −0.8d | <.001 |
Sense of control (0–10c) | 4.8 (2.47) | 5.7 (2.28) | 5.8 (2.37) | 6.1 (2.45) | 1.3d | <.001 |